Fig. 4From: Knockdown of circSMAD2 inhibits the tumorigenesis of gallbladder cancer through binding with eIF4A3CircSMAD2 bound with eIF4A3. (A) The enrichment of SMAD2 was tested by RIP. (B, C) The mRNA stability of SMAD2 in actinomycin D-treated GBC cells was analyzed by RT-qPCR. **P < 0.01 compared to controlBack to article page